Immunoconjugate Therapy of Hematologic Malignancies Gisela The research instruments were tested

The research instruments were tested for validity and reliability prior to being used in the field

big traditional retail players have missed the chance to develop accordingly to the pace of technological developments

and consumption

Die vorliegende Arbeit beschäftigt sich mit der Legasthenie und ihren möglichen sozialen Komplikationen

in close collaboration with him

Immunoconjugate Therapy of Hematologic Malignancies Gisela The research instruments were testedThe hybridoma technique for producing monoclonal antibodies developed by Drs. Kohler and Millstein in 1975 revolutionized the field of tumor immunology. It is now clear that there are antigens associated with or restricted to human neoplasms that have biologic significance. Monoclonal antibodies have already been demonstrated to have great immunodiagnostic value, and it is anticipated that they will become a component of our therapeutic armamentarium.